Effects of a COVID-19 Public Health Lockdown on Drinking and Health Behavior Among Persons with HIV and with Unhealthy Alcohol use in Uganda.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Oct 2023
Historique:
accepted: 14 03 2023
medline: 25 9 2023
pubmed: 1 4 2023
entrez: 31 3 2023
Statut: ppublish

Résumé

To better understand the impact of Uganda's initial COVID-19 lockdown on alcohol use, we conducted a cross-sectional survey (August 2020-September 2021) among persons with HIV (PWH) with unhealthy alcohol use (but not receiving an alcohol intervention), enrolled in a trial of incentives to reduce alcohol use and improve isoniazid preventive therapy. We examined associations between bar-based drinking and decreased alcohol use, and decreased alcohol use and health outcomes (antiretroviral therapy [ART] access, ART adherence, missed clinic visits, psychological stress and intimate partner violence), during lockdown. Of 178 adults surveyed whose data was analyzed, (67% male, median age: 40), 82% reported bar-based drinking at trial enrollment; 76% reported decreased alcohol use during lockdown. In a multivariate analysis, bar-based drinking was not associated with greater decreases in alcohol use during lockdown compared to non-bar-based drinking (OR = 0.81, 95% CI: 0.31-2.11), adjusting for age and sex. There was a significant association between decreased alcohol use and increased stress during lockdown (adjusted β = 2.09, 95% CI: 1.07-3.11, P < 0.010), but not other health outcomes.

Identifiants

pubmed: 37000383
doi: 10.1007/s10461-023-04042-y
pii: 10.1007/s10461-023-04042-y
pmc: PMC10063928
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3213-3222

Subventions

Organisme : NIAAA NIH HHS
ID : K23 AA029045
Pays : United States
Organisme : NIAAA NIH HHS
ID : K24 AA022586
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01AA026221
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01AA026223
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

BMC Public Health. 2022 Jan 13;22(1):88
pubmed: 35027023
Alcohol Clin Exp Res. 2019 Dec;43(12):2591-2598
pubmed: 31610017
Biochim Biophys Acta. 1984 Mar 27;793(1):119-22
pubmed: 6704410
J Health Psychol. 2013 Dec;18(12):1617-28
pubmed: 24155195
J Acquir Immune Defic Syndr. 2021 Dec 15;88(5):448-456
pubmed: 34757973
Addict Sci Clin Pract. 2017 Sep 27;12(1):22
pubmed: 28950912
Drug Alcohol Rev. 2017 Jan;36(1):7-9
pubmed: 27305859
AIDS. 2020 Mar 1;34(3):405-413
pubmed: 31725431
PLoS One. 2022 Feb 16;17(2):e0263827
pubmed: 35171949
Curr Opin Psychol. 2017 Feb;13:153-157
pubmed: 28497106
Soc Sci Med. 2015 Apr;131:131-46
pubmed: 25771482
AIDS Behav. 2021 Nov;25(11):3758-3769
pubmed: 33876383
Afr J Emerg Med. 2021 Jun;11(2):227-230
pubmed: 33520631
World Dev. 2021 Jan;137:105199
pubmed: 32982018
PLoS One. 2021 Feb 22;16(2):e0247456
pubmed: 33617579
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Alcohol Alcohol. 2006 Jul-Aug;41(4):431-7
pubmed: 16624837
Trials. 2021 May 20;22(1):355
pubmed: 34016158
J Int AIDS Soc. 2021 Oct;24 Suppl 6:e25794
pubmed: 34713578
AIDS Care. 2017 Nov;29(11):1442-1447
pubmed: 28278568
AIDS Behav. 2019 Jan;23(1):140-151
pubmed: 29995206
BMC Public Health. 2012 Jun 06;12:399
pubmed: 22672439
PLoS One. 2018 Aug 27;13(8):e0202992
pubmed: 30148854
Alcohol Clin Exp Res. 2022 Apr;46(4):498-513
pubmed: 35412673
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Afr J Emerg Med. 2021 Dec;11(4):477-482
pubmed: 34490069
Drug Alcohol Rev. 2020 May;39(4):301-304
pubmed: 32358884
J Addict Med. 2021 Jan-Feb 01;15(1):3-7
pubmed: 32482955
S Afr Med J. 2021 Jul 02;111(9):834-837
pubmed: 34949245
Lancet HIV. 2021 Mar;8(3):e158-e165
pubmed: 33549166
Addiction. 2011 May;106(5):906-14
pubmed: 21382111
Alcohol Clin Exp Res. 2015 May;39(5):905-10
pubmed: 25866234
Psychol Addict Behav. 2022 Feb;36(1):1-19
pubmed: 34807630
J Acquir Immune Defic Syndr. 2022 Apr 15;89(5):511-518
pubmed: 34954717
Epidemiol Health. 2020;42:e2020038
pubmed: 32512661
Stress Health. 2020 Aug;36(3):396-401
pubmed: 32588961
PLoS One. 2014 Dec 01;9(12):e113152
pubmed: 25436894
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Clin Infect Dis. 2021 Oct 5;73(7):e1964-e1972
pubmed: 32905581
AIDS Behav. 2019 Jun;23(6):1656-1667
pubmed: 30560484
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551

Auteurs

Brian Beesiga (B)

Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda.

Kara Marson (K)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Robin Fatch (R)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Nneka I Emenyonu (NI)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Julian Adong (J)

Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.

Allen Kekibiina (A)

Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.

Sarah Puryear (S)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Sara Lodi (S)

Boston University School of Public Health, Boston, MA, USA.

Michael G McDonell (MG)

Elson S Floyd College of Medicine, Washington State University, Spokane, WA, USA.

Winnie R Muyindike (WR)

Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Mbarara Regional Referral Hospital, Mbarara, Uganda.

Moses R Kamya (MR)

Infectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Department of Medicine, Makerere University, Kampala, Uganda.

Judith A Hahn (JA)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.

Gabriel Chamie (G)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. Gabriel.Chamie@ucsf.edu.
San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, 94110, USA. Gabriel.Chamie@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH